LBA-16 NEPHRON-SPARING MANAGEMENT OF LOW GRADE (LG) UTUC WITH UGN-101 (MITOMYCIN GEL) FOR INSTILLATION: THE OLYMPUS TRIAL EXPERIENCE

Authors :: Scott G. Hubosky
Mark P. Schoenberg
Douglas S. Scherr
John C. Gore
Marcelino Rivera
Marcus L. Quek
Nir Kleinmann
Angela Smith VChapel
Michael Verni
Christopher J. Weight
Hristos Z. Kaimakliotis
Michael A. O’Donnell
Guy Godoy
Mitchell R. Humphreys
Joshua M. Stern
Alon Z. Weizer
Michael Woods
David A. Lifshitz
Ifat Klein
Ahmad Shabsigh
Philip Pierorazio
Jennifer Linehan
Jonathan A. Coleman
Brian Hu
Karim Chamie
Jay D. Raman
Seth P. Lerner
Surena F. Matin
Elyse Seltzer
Raymond Pak
Source :: Journal of Urology. 201
Publication Year :: 2019
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2019.
Abstract: INTRODUCTION AND OBJECTIVES:Only 30% of UTUC patients receive endoscopic, nephron-sparing treatments due to (1) high grade histology, (2) tumor burden, or (3) unfavorable tumor location. Endoscopic...

Subjects :: 03 medical and health sciences
medicine.medical_specialty
0302 clinical medicine
business.industry
Urology
030232 urology & nephrology
medicine
Tumor burden
Histology
Nephron sparing surgery
Tumor location
business

Tools